BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2314383)

  • 1. [Augmentation of cytotoxicity of regional lymph node lymphocytes of gastric cancer after intratumoral injection of OK-432].
    Kobayashi G
    Nihon Geka Gakkai Zasshi; 1990 Jan; 91(1):68-76. PubMed ID: 2314383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Endoscopic preoperative intralesional injection of OK-432 in early gastric cancer].
    Yamane T; Sagara Y; Suzuki G; Kasuga M; Sakita M; Fujita Y; Majima S
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):930-4. PubMed ID: 6721507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of advanced gastric cancer responsive to intratumoral OK-432 injection].
    Sakai Y; Maeda M; Koyama W; Totsuka S; Sakamoto S; Kanayama M
    Gan To Kagaku Ryoho; 1988 Jun; 15(6):1978-80. PubMed ID: 3382244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Observation on natural killer cell activity in gastric cancer patients and effect of nonspecific immunopotentiator administration on its postoperative reduction].
    Oshita H; Saji S; Sugiyama Y; Tanemura H; Sakata K; Tanaka S; Ito T
    Nihon Geka Gakkai Zasshi; 1985 Oct; 86(10):1417-25. PubMed ID: 4079897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of intratumoral injection of the mixture of OK-432 and fibrinogen (OK/fbg) on gastric cancer].
    Takeda T; Wakasugi T; Katsumoto Y; Sakita I; Nagaoka H; Morimoto H; Tsujinaka T; Monden T; Shiozaki H; Shimano T
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1458-60. PubMed ID: 1530293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The immune defense system in gastric cancer tissue, regional lymph node and spleen--aspects from subsets and functions of lymphocytes].
    Tanaka N; Gohchi A; Akura Y; Gotoh K; Okabayashi T; Horimi T; Orita K
    Nihon Geka Gakkai Zasshi; 1985 Sep; 86(9):1112-5. PubMed ID: 4088222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of immunological response of regional lymph node lymphocytes from patients with gastric cancer after endoscopic local injection of biological response modifier (BRM)].
    Obi Y
    Nihon Geka Gakkai Zasshi; 1991 Mar; 92(3):293-302. PubMed ID: 2051981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A double blind study to evaluate the optimal dose and its frequency for oral administration of OK-432 (picibanil) by immunological parameters (the 2nd report)].
    Shiraishi T; Nio Y; Imai S; Tsubono M; Morimoto H; Tseng CC; Tobe T; Tanaka T; Kitamura O; Sakanashi S
    Nihon Gan Chiryo Gakkai Shi; 1990 May; 25(5):997-1012. PubMed ID: 2202770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Endoscopic administration of OK-432 in gastric cancer].
    Inbe A; Sumii K; Haruma K; Uemura N; Tari A; Yoshihara M; Tokutomi T; Inaba Y; Sekito M; Ogoshi H
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):514-9. PubMed ID: 3954375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A clinical study of immunological status in gastric cancer patients--with special reference to T-cell subsets in the lymphocytes of regional lymph nodes].
    Ohwada S; Takeshita M; Miyamoto Y; Izumi M
    Nihon Geka Gakkai Zasshi; 1990 Oct; 91(10):1560-6. PubMed ID: 2263239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preoperative immunotherapy in patients with gastric cancer--with special reference to analysis with monoclonal antibodies of T-lymphocyte subsets and interleukin-2 oral administration of OK-432 (Picibanil)].
    Izumi M
    Nihon Geka Gakkai Zasshi; 1993 Jan; 94(1):27-32. PubMed ID: 8437550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of endoscopic local injection of OK-432 on regional lymph nodes in gastric cancer patients].
    Ogawara T; Sakai K; Sekikawa T; Kouno K; Matsumoto Y
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1601-4. PubMed ID: 1530316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A double blind study of the evaluation of the optimal dose and its frequency in oral administration of OK-432 (Picibanil) by immunological parameters (the 1st report)].
    Shiraishi T; Nio Y; Imai S; Tsubono M; Morimoto H; Tseng CC; Tobe T; Tanaka T; Kitamura O; Sakanashi S
    Nihon Gan Chiryo Gakkai Shi; 1990 Apr; 25(4):799-811. PubMed ID: 2196311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Subsets of peripheral blood lymphocytes and tumor infiltrating lymphocytes in cancer patients received chemotherapy].
    Mitachi Y; Murakawa Y; Okuno M; Kambe M; Kanamaru R; Takahasi H; Wakui A
    Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 2):482-8. PubMed ID: 2138871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical study on the effect of intratumoral administration of OK-432 on breast cancer--anti-tumor immune response at the site of local injection].
    Hosokawa T
    Nihon Geka Gakkai Zasshi; 1991 May; 92(5):577-86. PubMed ID: 1831533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmentation in cytotoxicity of lymphnode lymphocytes by OK-432.
    Tanaka N; Gotoh K; Kobayashi G; Gouchi A; Orita K
    Int J Immunopharmacol; 1994 Feb; 16(2):131-5. PubMed ID: 8181902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies on the enhancement of anti-tumor activity in patients with cervical cancer by local administration of OK-432].
    Yamada Y; Yamamoto K; Wakita K; Shiraki S; Noda K
    Gan To Kagaku Ryoho; 1986 Dec; 13(12):3427-31. PubMed ID: 3789753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of NK activity in regional lymph nodes by preoperative immunotherapy with OK-432 in patients with cancer of the oral cavity.
    Vinzenz K; Matejka M; Watzek G; Porteder H; Neuhold N; Micksche M
    Cancer Detect Prev Suppl; 1987; 1():463-75. PubMed ID: 3480060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of biological response modifier on thoracic duct lymphocytes in recurrent gastric cancer. Evaluation of OK-432, a hemolytic streptococcus preparation.
    Hanaue H; Kim DY; Kubota M; Kurosawa T; Shikata J; Kondoh Y; Ogoshi K; Makuuchi H; Nakasaki H; Mitomi T
    Tokai J Exp Clin Med; 1987 May; 12(2):97-102. PubMed ID: 3502432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Oral administration of OK-432 (picibanil). (8th report) clinical application: its immunomodulatory effects on the patients with gastrointestinal cancers].
    Nio Y; Ohgaki K; Tsuchitani T; Imai S; Shiraishi T; Tsubono M; Morimoto H; Tseng CC; Tobe T
    Nihon Gan Chiryo Gakkai Shi; 1989 Aug; 24(8):1607-15. PubMed ID: 2809385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.